Isoniazid/pyridoxine/sulfamethoxazole/trimethoprim
- Level
- Commodity
- Parent
- 51162100
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51162104This classification is for a combination therapy used for prophylaxis against multiple opportunistic infections in people living with HIV. The first component, ISONIAZID, has US FDA Unique Ingredient Identifier of V83O1VOZ8L. ISONIAZIDis an International Non-Proprietary Name or INN. The second component, PYRIDOXINE, has US FDA Unique Ingredient Identifier of KV2JZ1BI6Z. The third component, SULFAMETHOXAZOLE, has US FDA Unique Ingredient Identifier of JE42381TNV. The fourth component, TRIMETHOPRIM, has US FDA Unique Ingredient Identifier of AN164J8Y0X.
Same parent
Under 51162100 · 7Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.